Abstract
Adult Still's disease (ASD) is a systemic rheumatic disease characterized by high spiking fever, erythema, polyarthritis, and increased levels of C-reactive protein, ferritin, and interleukin (IL)-18. Recently, biological agents targeting proinflammatory cytokines such as tumor necrosis factor (TNF) α, IL-1, and IL-6 have been described as effective treatments for refractory ASD. Herein, we present a patient with ASD, who was successfully treated by tacrolimus concomitant with corticosteroid, while infliximab and etanercept were not effective. Tacrolimus may be one of the drugs for the ASD patients refractory to the conventional treatments including TNF inhibitors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A Ohta M Yamaguchi H Kaneoka T Nagayoshi M Hiida (1987) ArticleTitleAdult Still's disease: review of 228 cases from the literature J Rheumatol 14 1139–46 Occurrence Handle3325642 Occurrence Handle1:STN:280:DyaL1c7ktFWrsQ%3D%3D
M Kawashima M Yamamura M Taniai H Yamauchi T Tanimoto M Kurimoto et al. (2001) ArticleTitleLevels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease Arthritis Rheum 44 550–60 Occurrence Handle11263769 Occurrence Handle10.1002/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5 Occurrence Handle1:CAS:528:DC%2BD3MXislags74%3D
T Hoshino A Ohta M Nakao T Ota T Inouchi S Matsueda et al. (1993) ArticleTitleTCRγδ+ T cells in peripheral blood of patients with adult Still's disease J Rheumatol 23 124–9
T Fujii H Nojima S Yasuoka S Satoh M Nakamura M Kuwana et al. (2001) ArticleTitleCytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease Rheumatology 40 1398–404 Occurrence Handle11752512 Occurrence Handle10.1093/rheumatology/40.12.1398 Occurrence Handle1:STN:280:DC%2BD38%2FgsVGgsA%3D%3D
AA Fitzgerald SA LeClercq A Yan JE Homik CA Dinarello (2005) ArticleTitleRapid responses to anakinra in patients with refractory adult-onset Still's disease Arthritis Rheum 52 1794–803 Occurrence Handle15934079 Occurrence Handle10.1002/art.21061 Occurrence Handle1:CAS:528:DC%2BD2MXlvFChurs%3D
M Iwamoto H Nara D Hirata S Minota N Nishimoto K Yoshizaki (2002) ArticleTitleHumanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease Arthritis Rheum 46 3388–9 Occurrence Handle12483747 Occurrence Handle10.1002/art.10620 Occurrence Handle1:CAS:528:DC%2BD3sXjslGgsw%3D%3D
HG Kraetsch C Antoni JR Kalden B Manger (2001) ArticleTitleSuccessful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences Ann Rheum Dis 60 55–7 Occurrence Handle10.1136/ard.60.1.55
ME Husni AL Maier PJ Mease SS Overman P Fraser EM Gravallese et al. (2002) ArticleTitleEtanercept in the treatment of adult patients with Still's disease Arthritis Rheum 46 1171–6 Occurrence Handle12115220 Occurrence Handle10.1002/art.10231 Occurrence Handle1:CAS:528:DC%2BD38XksVyguro%3D
B Fautrel J Sibilia X Mariette B Combe the Club (2005) ArticleTitleRhumatismes Et Inflammation. Tumour necrosis factor α blocking agents in refractory adult Still's disease: an observational study of 20 cases Ann Rheum Dis 64 262–6 Occurrence Handle15184196 Occurrence Handle10.1136/ard.2004.024026 Occurrence Handle1:CAS:528:DC%2BD2MXhvFyrur8%3D
O Saiki H Uda N Nishimoto T Miwa T Mima T Ogawara et al. (2004) ArticleTitleAdult Still's disease reflects a Th2 rather than a Th1 cytokine profile Clin Immunol 112 120–5 Occurrence Handle15207789 Occurrence Handle10.1016/j.clim.2004.03.023 Occurrence Handle1:CAS:528:DC%2BD2cXltVOisrc%3D
M Yamaguchi A Ohta T Tsunematsu R Kasukawa Y Mizushima H Kashiwagi et al. (1992) ArticleTitlePreliminary criteria for classification of adult Still's disease J Rheumatol 19 424–30 Occurrence Handle1578458 Occurrence Handle1:STN:280:DyaK383ltFOlsw%3D%3D
DY Chen JL Lan FJ Lin TY Hsieh MC Wen (2004) ArticleTitlePredominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease Ann Rheum Dis 63 1300–6 Occurrence Handle15361391 Occurrence Handle10.1136/ard.2003.013680 Occurrence Handle1:CAS:528:DC%2BD2cXovFOms7w%3D
T Sugiura Y Kawaguchi M Harigai H Terajima-Ichida Y Kitamura T Furuya et al. (2002) ArticleTitleAssociation between adult-onset Still's disease and interleukin-18 gene polymorphisms Genes Immun 3 394–7 Occurrence Handle12424620 Occurrence Handle10.1038/sj.gene.6363922 Occurrence Handle1:CAS:528:DC%2BD38XosFamurs%3D
M Kuinose H Iwagaki Y Morimoto H Kohka et al. (2000) ArticleTitleCalcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions Acta Med Okayama 54 201–9 Occurrence Handle11061569 Occurrence Handle1:CAS:528:DC%2BD3cXotVKiur4%3D
T Fujii M Akizuki H Kameda M Matsumura M Hirakata T Yoshida et al. (1997) ArticleTitleMethotrexate treatment in patients with adult onset Still's disease–retrospective study of 13 Japanese cases Ann Rheum Dis 56 144–8 Occurrence Handle9068291 Occurrence Handle1:STN:280:DyaK2s3itFantw%3D%3D Occurrence Handle10.1136/ard.56.2.144
A Marchesoni GP Ceravolo N Battafarano A Rossetti S Tosi F Fantini (1997) ArticleTitleCyclosporin A in the treatment of adult onset Still's disease J Rheumatol 24 1582–7 Occurrence Handle9263155 Occurrence Handle1:CAS:528:DyaK2sXls1Sgu7Y%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Murakami, K., Fujii, T., Yukawa, N. et al. Successful treatment of a patient with refractory adult Still's disease by tacrolimus. Mod Rheumatol 17, 167–170 (2007). https://doi.org/10.1007/s10165-006-0559-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-006-0559-2